315 related articles for article (PubMed ID: 16902972)
1. Prostate cancer metastasis: role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis.
Xu J; Wang R; Xie ZH; Odero-Marah V; Pathak S; Multani A; Chung LW; Zhau HE
Prostate; 2006 Nov; 66(15):1664-73. PubMed ID: 16902972
[TBL] [Abstract][Full Text] [Related]
2. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
3. [Epithelial-mesenchymal transition in cancer progression].
Gos M; Miłoszewska J; Przybyszewska M
Postepy Biochem; 2009; 55(2):121-8. PubMed ID: 19824467
[TBL] [Abstract][Full Text] [Related]
4. Receptor activator of NF-kappaB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells.
Odero-Marah VA; Wang R; Chu G; Zayzafoon M; Xu J; Shi C; Marshall FF; Zhau HE; Chung LW
Cell Res; 2008 Aug; 18(8):858-70. PubMed ID: 18645583
[TBL] [Abstract][Full Text] [Related]
5. Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells.
Veveris-Lowe TL; Lawrence MG; Collard RL; Bui L; Herington AC; Nicol DL; Clements JA
Endocr Relat Cancer; 2005 Sep; 12(3):631-43. PubMed ID: 16172196
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2.
Chaffer CL; Brennan JP; Slavin JL; Blick T; Thompson EW; Williams ED
Cancer Res; 2006 Dec; 66(23):11271-8. PubMed ID: 17145872
[TBL] [Abstract][Full Text] [Related]
7. Silibinin reverses epithelial-to-mesenchymal transition in metastatic prostate cancer cells by targeting transcription factors.
Wu K; Zeng J; Li L; Fan J; Zhang D; Xue Y; Zhu G; Yang L; Wang X; He D
Oncol Rep; 2010 Jun; 23(6):1545-52. PubMed ID: 20428808
[TBL] [Abstract][Full Text] [Related]
8. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
Buijs JT; Henriquez NV; van Overveld PG; van der Horst G; Que I; Schwaninger R; Rentsch C; Ten Dijke P; Cleton-Jansen AM; Driouch K; Lidereau R; Bachelier R; Vukicevic S; Clézardin P; Papapoulos SE; Cecchini MG; Löwik CW; van der Pluijm G
Cancer Res; 2007 Sep; 67(18):8742-51. PubMed ID: 17875715
[TBL] [Abstract][Full Text] [Related]
9. Human kallikrein 7 induces epithelial-mesenchymal transition-like changes in prostate carcinoma cells: a role in prostate cancer invasion and progression.
Mo L; Zhang J; Shi J; Xuan Q; Yang X; Qin M; Lee C; Klocker H; Li QQ; Mo Z
Anticancer Res; 2010 Sep; 30(9):3413-20. PubMed ID: 20944116
[TBL] [Abstract][Full Text] [Related]
10. Epithelial to mesenchymal transition (EMT) in human prostate cancer: lessons learned from ARCaP model.
Zhau HE; Odero-Marah V; Lue HW; Nomura T; Wang R; Chu G; Liu ZR; Zhou BP; Huang WC; Chung LW
Clin Exp Metastasis; 2008; 25(6):601-10. PubMed ID: 18535913
[TBL] [Abstract][Full Text] [Related]
11. Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells.
Wu GJ; Peng Q; Fu P; Wang SW; Chiang CF; Dillehay DL; Wu MW
Gene; 2004 Mar; 327(2):201-13. PubMed ID: 14980717
[TBL] [Abstract][Full Text] [Related]
12. Characterization of LMX-1A as a metastasis suppressor in cervical cancer.
Liu CY; Chao TK; Su PH; Lee HY; Shih YL; Su HY; Chu TY; Yu MH; Lin YW; Lai HC
J Pathol; 2009 Oct; 219(2):222-31. PubMed ID: 19644956
[TBL] [Abstract][Full Text] [Related]
13. RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes.
Armstrong AP; Miller RE; Jones JC; Zhang J; Keller ET; Dougall WC
Prostate; 2008 Jan; 68(1):92-104. PubMed ID: 18008334
[TBL] [Abstract][Full Text] [Related]
14. Type I collagen receptor (alpha 2 beta 1) signaling promotes the growth of human prostate cancer cells within the bone.
Hall CL; Dai J; van Golen KL; Keller ET; Long MW
Cancer Res; 2006 Sep; 66(17):8648-54. PubMed ID: 16951179
[TBL] [Abstract][Full Text] [Related]
15. In vivo models of prostate cancer metastasis to bone.
Singh AS; Figg WD
J Urol; 2005 Sep; 174(3):820-6. PubMed ID: 16093963
[TBL] [Abstract][Full Text] [Related]
16. A Nod Scid mouse model to study human prostate cancer.
Bastide C; Bagnis C; Mannoni P; Hassoun J; Bladou F
Prostate Cancer Prostatic Dis; 2002; 5(4):311-5. PubMed ID: 12627217
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment.
Tse JC; Kalluri R
J Cell Biochem; 2007 Jul; 101(4):816-29. PubMed ID: 17243120
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness.
Giannoni E; Bianchini F; Masieri L; Serni S; Torre E; Calorini L; Chiarugi P
Cancer Res; 2010 Sep; 70(17):6945-56. PubMed ID: 20699369
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer progression into androgen independency is associated with alterations in cell adhesion and invasivity.
Jennbacken K; Gustavsson H; Welén K; Vallbo C; Damber JE
Prostate; 2006 Nov; 66(15):1631-40. PubMed ID: 16927303
[TBL] [Abstract][Full Text] [Related]
20. [Expression of "epithelial-mesenchymal transition" associated proteins in prostate cancer cell lines with different metastatic potentials and its significance].
Luo Y; He DL; Ning L
Zhonghua Nan Ke Xue; 2006 Aug; 12(8):696-700. PubMed ID: 16970156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
